Extensive persistent inflammation even when SARS-CoV-2-infected cells are only sporadically present at late stages of COVID-19 (Schurink et al., 2020) could also justify low GSH levels in association with over-abundance of cellular ROS, cellular oxidative damage, increased inflammation and cell death pathways activation seen in inflammaging (Zuo et al., 2019
Now, Im going to share some dosages with you that I found from the internet And by internet, I mean online forums not published literature
In those situations, a thoughtful approach to glutathione use, combined with careful clinical evaluation, can help determine whether it may play a supportive role within a broader care plan
reported greater weight loss in obese mice with the GLP-1/GIP/glucagon receptor triagonist compared to GLP-1 receptor agonists, GIP/GLP-1 receptor co-agonists and GLP-1/glucagon receptor agonists including semaglutide and tirzepatide [60]
It means there's a considered range, and the honest move is to pick a defensible point inside it and tell you what it is
For example, if the initial benefits wane, the dosage or frequency of injections may need to be adjusted